Stock SERA SERA PROGNOSTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Sera Prognostics, Inc.

Equities

SERA

US81749D1072

Market Closed - Nasdaq
Other stock markets
 21:00:00 30/04/2024 BST 		5-day change 1st Jan Change
11.69 USD +4.84% Intraday chart for Sera Prognostics, Inc. +17.37% +95.48%
03-28 Sera Prognostics Insider Sold Shares Worth $727,853, According to a Recent SEC Filing MT
03-27 Sera Prognostics Insider Sold Shares Worth $364,484, According to a Recent SEC Filing MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2024 Financial Results on May 8, 2024
PR
Sera Prognostics Insider Sold Shares Worth $727,853, According to a Recent SEC Filing
MT
Sera Prognostics Insider Sold Shares Worth $364,484, According to a Recent SEC Filing
MT
Transcript : Sera Prognostics, Inc., 2023 Earnings Call, Mar 20, 2024
Earnings Flash (SERA) SERA PROGNOSTICS Posts Q4 Revenue $41,000
MT
Sera Prognostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Sera Prognostics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
SERA PROGNOSTICS REPORTS FOURTH QUARTER 2023 FINANCIAL RESULTS
PR
Sera Prognostics Announces Conference Call and Webcast of Fourth Quarter and Fiscal Year 2023 Financial Results on March 20, 2024
PR
Sera Prognostics To Present at TD Cowen 44th Annual Healthcare Conference
PR
Sector Update: Health Care Stocks Mixed Late Afternoon
MT
Top Midday Gainers
MT
Sector Update: Health Care Stocks Rise in Afternoon Trading
MT
Sector Update: Health Care
MT
Sera Prognostics Says Study of Preterm Birth Prevention Strategy Met Primary Endpoint Criteria; Shares Surge
MT
SERA PROGNOSTICS ANNOUNCES PRIMARY ENDPOINT CRITERIA MET IN PIVOTAL PRIME STUDY INTERIM LOOK - ENROLLMENT TO STOP DUE TO SUCCESS
PR
Sera Prognostics Inc. Announces Preliminary Efficacy Met in Pivotal Prime Study Interim Look - Enrollment to Stop Due to Success
CI
SERA PROGNOSTICS TO PRESENT AT 35TH ANNUAL PIPER SANDLER HEALTHCARE CONFERENCE
PR
Transcript : Sera Prognostics, Inc., Q3 2023 Earnings Call, Nov 08, 2023
Earnings Flash (SERA) SERA PROGNOSTICS Posts Q3 Revenue $42,000
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SERA Stock
  4. News Sera Prognostics, Inc.